Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favorable benefit-safety profile
Article in Expert Opinion on Drug Safety (May 2024)
The most recent citing publications are shown below. View all 97 publications that cite this research output on Dimensions.
Article in Expert Opinion on Drug Safety (May 2024)
Article in Diabetes Technology & Therapeutics (April 2024)
Article in Diabetes Therapy (April 2024)